During the past decade, Arizona Oncology Associates-West Orange Grove conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 10 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Oncology Associates-West Orange Grove" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology Associates-West Orange Grove" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Oncology Associates-West Orange Grove" are "Prostate Cancer" (3 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials), "Glioblastoma" (2 trials) and "Gliosarcoma" (2 trials). Many other conditions were trialed in "Arizona Oncology Associates-West Orange Grove" in a lesser frequency.

Most popular intervention types in "Arizona Oncology Associates-West Orange Grove" are "Radiation" (11 trials), "Drug" (10 trials), "Other" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (6 trials), "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (5 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Oncology Associates-West Orange Grove" are 7 trials for "Female" genders, 6 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Arizona Oncology Associates-West Orange Grove". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Arizona Oncology Associates-West Orange Grove, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Oncology Associates-West Orange Grove, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".